The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective
Abstract
Expectation/placebo-related mechanisms and specific effects of therapies show additive effects, such that a therapy is less effective if the placebo component is absent. So far, the placebo component has been disrupted experimentally by using covert administrations of treatments. Here, we show for the first time that disruption of expectation/placebo-related analgesic mechanisms may occur in a clinical condition, Alzheimer's disease (AD). In order to assess the placebo component of a therapy, we used the recently developed open-hidden paradigm. A local anesthetic was applied, either overtly or covertly, to the skin of AD patients to reduce burning pain after venipuncture. The placebo (psychological) component is represented by the difference between the analgesic effect after open (expected) and after hidden (unexpected) application. We correlated the placebo component with both cognitive status and functional connectivity among different brain regions. We found that AD patients with reduced Frontal Assessment Battery scores showed reduced placebo component of the analgesic treatment. We also found that the disruption of the placebo component occurred when reduced connectivity of the prefrontal lobes with the rest of the brain was present. Remarkably, the loss of these placebo-related mechanisms reduced treatment efficacy, such that a dose increase was necessary to produce adequate analgesia. These findings highlight the active role of cognition and prefrontal lobes in the therapeutic outcome and underscore the need of considering a possible revision of the therapeutic approach in Alzheimer patients in order to compensate for the loss of the endogenous expectation and placebo mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The FAB: A frontal assessment battery at bedside
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913
Placebo-Induced Changes in fMRI in the Anticipation and Experience of Pain
Wager, T. D., Rilling, J. K., Smith, E. E., Sokolik, A., Casey, K. L., Davidson, R. J., Kosslyn, S. M., Rose, R. M., & Cohen, J. D. (2004) · Science · doi:10.1126/science.1093065 · Cited by 1,992
Placebo and Opioid Analgesia-- Imaging a Shared Neuronal Network
Petrovic, P., Kalso, E., Petersson, K. M., & Ingvar, M. (2002) · Science · doi:10.1126/science.1067176 · Cited by 1,488 · cited 4×
“Interestingly, similar regions have been found to be activated by placebos (Petrovic et al., 2002, 2005; Lieberman et al., 2004; Wager et al., 2004).”
BackgroundResultInfluentialThe Clinical Diagnosis of Alzheimer's Disease
Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,374
EEG dynamics in patients with Alzheimer's disease
Jeong, J. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.01.001 · Cited by 1,337
Dynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132
THE MECHANISM OF PLACEBO ANALGESIA
Levine, J., Gordon, N., & Fields, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92762-9 · Cited by 1,094
Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease
de la Fuente-Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B., & Stoessl, A. J. (2001) · Science · doi:10.1126/science.1060937 · Cited by 991
Amanzio, M., & Benedetti, F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00484.1999 · Cited by 899
Self-citationKonishi, S., Nakajima, K., Uchida, I., Kikyo, H., Kameyama, M., & Miyashita, Y. (1999) · Brain · doi:10.1093/brain/122.5.981 · Cited by 823
Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04315.2003 · Cited by 788
Self-citationNeurobiological Mechanisms of the Placebo Effect
Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J.-K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3458-05.2005 · Cited by 777
Self-citationThe Functional Neuroanatomy of the Placebo Effect
Mayberg, H. S., Silva, J. A., Brannan, S. K., Tekell, J. L., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.728 · Cited by 720
TREATMENT OF EXCESSIVE AXILLARY SWEATING
Gibbs, J. R. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91979-5 · Cited by 559
Overt versus covert treatment for pain, anxiety, and Parkinson's disease
Colloca, L., Lopiano, L., Lanotte, M., & Benedetti, F. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00908-1 · Cited by 552
Self-citationBerman, K. (1995) · Neuropsychologia · doi:10.1016/0028-3932(95)00035-2 · Cited by 534 · cited 1×
“…with specific ¼ HðR; T Þ HðT Þ; frontal areas in previous studies, for example, abstract reasoning with dorsolateral frontal regions and inhibitory control with orbital and medial frontal areas (Berman et al., 1995; Nagahama et al., 1996; Rolls et al., 1996; Konishi et al., 1998, 1999a,b).”
Placebos and painkillers: is mind as real as matter?
Colloca, L., & Benedetti, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1705 · Cited by 465
Self-citationPetrovic, P., Dietrich, T., Fransson, P., Andersson, J., Carlsson, K., & Ingvar, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.023 · Cited by 437 · cited 3×
“Interestingly, similar regions have been found to be activated by placebos (Petrovic et al., 2002, 2005; Lieberman et al., 2004; Wager et al., 2004).”
BackgroundResultResponse variability to analgesics: a role for non-specific activation of endogenous opioids
Amanzio, M., Pollo, A., Maggi, G., & Benedetti, F. (2001) · Pain · doi:10.1016/s0304-3959(00)00486-3 · Cited by 421
Self-citationTransient activation of inferior prefrontal cortex during cognitive set shifting
Konishi, S., Nakajima, K., Uchida, I., Kameyama, M., Nakahara, K., Sekihara, K., & Miyashita, Y. (1998) · Nature Neuroscience · doi:10.1038/283 · Cited by 401
Orbitofrontal cortex neurons: role in olfactory and visual association learning
Rolls, E. T., Critchley, H. D., Mason, R., & Wakeman, E. A. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.75.5.1970 · Cited by 398
Mutual information analysis of the EEG in patients with Alzheimer's disease
Jeong, J., Gore, J. C., & Peterson, B. S. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(01)00513-2 · Cited by 397 · cited 3×
“As AD patients show decreased electroencephalogram (EEG) coherence (Jeong, 2004), we also analyzed the functional connectivity among different brain regions by means of EEG mutual information analysis (Jeong et al., 2001; Na et al., 2002; Min et al., 2003; David et al., 2004; Hurtado et al., 2004).”
MethodChanges in Brain Function of Depressed Subjects During Treatment With Placebo
Leuchter, A. F., Cook, I. A., Witte, E. A., Morgan, M., & Abrams, M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.122 · Cited by 396
Somatotopic Activation of Opioid Systems by Target-Directed Expectations of Analgesia
Benedetti, F., Arduino, C., & Amanzio, M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03639.1999 · Cited by 350
Self-citationEvaluation of different measures of functional connectivity using a neural mass model
David, O., Cosmelli, D., & Friston, K. J. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.10.006 · Cited by 339
Influence of the method of drug administration on analgesic response
Levine, J. D., & Gordon, N. C. (1984) · Nature · doi:10.1038/312755a0 · Cited by 323
Benedetti, F., Colloca, L., Torre, E., Lanotte, M., Melcarne, A., Pesare, M., Bergamasco, B., & Lopiano, L. (2004) · Nature Neuroscience · doi:10.1038/nn1250 · Cited by 309
Self-citationVolkow, N. D., Wang, G.-J., Ma, Y., Fowler, J. S., Zhu, W., Maynard, L., Telang, F., Vaska, P., Ding, Y.-S., Wong, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-36-11461.2003 · Cited by 302 · cited 2×
“…an outcome, is more effective than a hidden (unexpected) one, in which the subject does not know that any therapy is being given (Levine et al., 1981; Levine and Gordon, 1984; Benedetti et al., 1995; Amanzio et al., 2001; Volkow et al., 2003; Colloca et al., 2004; Colloca and Benedetti, 2005).”
BackgroundThe neural correlates of placebo effects: a disruption account
Lieberman, M. D., Jarcho, J. M., Berman, S., Naliboff, B. D., Suyenobu, B. Y., Mandelkern, M., & Mayer, E. A. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.01.037 · Cited by 289
Statistical Method for Detection of Phase-Locking Episodes in Neural Oscillations
Hurtado, J. M., Rubchinsky, L. L., & Sigvardt, K. A. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00853.2003 · Cited by 238
Pain processing in dementia and its relation to neuropathology
Scherder, E. J., Sergeant, J. A., & Swaab, D. F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00556-8 · Cited by 229
Potentiation of placebo analgesia by proglumide
Benedetti, F., Amanzio, M., & Maggi, G. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92938-x · Cited by 221
Self-citationPain threshold and tolerance in Alzheimer's disease
Benedetti, F., Vighetti, S., Ricco, C., Lagna, E., Bergamasco, B., Pinessi, L., & Rainero, I. (1999) · Pain · doi:10.1016/s0304-3959(98)00228-0 · Cited by 216
Self-citationRecent developments in pain in dementia
Scherder, E., Oosterman, J., Swaab, D., Herr, K., Ooms, M., Ribbe, M., Sergeant, J., Pickering, G., & Benedetti, F. (2005) · BMJ · doi:10.1136/bmj.330.7489.461 · Cited by 215
Self-citationCerebral activation during performance of a card sorting test
Nagahama, Y., Fukuyama, H., Yamauchi, H., Matsuzaki, S., Konishi, J., Shibasaki, H., & Kimura, J. (1996) · Brain · doi:10.1093/brain/119.5.1667 · Cited by 213
Konishi, S. (1999) · Cerebral Cortex · doi:10.1093/cercor/9.7.745 · Cited by 188
Mechanisms of the placebo response and their impact on clinical trials and clinical practice
Finniss, D. G., & Benedetti, F. (2005) · Pain · doi:10.1016/j.pain.2004.12.012 · Cited by 169
Self-citationEEG in schizophrenic patients: mutual information analysis
Na, S. H., Jin, S.-H., Kim, S. Y., & Ham, B.-J. (2002) · Clinical Neurophysiology · doi:10.1016/s1388-2457(02)00197-9 · Cited by 163
Analgesic responses to morphine and placebo in individuals with postoperative pain
Levine, J. D., Gordon, N. C., Smith, J., & Fields, H. L. (1981) · Pain · doi:10.1016/0304-3959(81)90099-3 · Cited by 153
Benedetti, F., Arduino, C., Vighetti, S., Asteggiano, G., Tarenzi, L., & Rainero, I. (2004) · Pain · doi:10.1016/j.pain.2004.05.015 · Cited by 119
Self-citationPrediction of treatment response to rivastigmine in Alzheimer's dementia.
Adler, G., Brassen, S., Chwalek, K., Dieter, B., & Teufel, M. (2004) · PubMed · Cited by 90
Assessing placebo effects without placebo groups: an untapped possibility?
Price, D. D. (2001) · Pain · doi:10.1016/s0304-3959(01)00265-2 · Cited by 62
The utility and generality of Mini‐Mental State Examination scores in Alzheimer's disease
Giordani, B., Boivin, M. J., Hall, A. L., Foster, N. L., Lehtinen, S., Bluemlein, L. A., & Berent, S. (1990) · Neurology · doi:10.1212/wnl.40.12.1894 · Cited by 60
Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients
Fogelson, N., Kogan, E., Korczyn, A. D., Giladi, N., Shabtai, H., & Neufeld, M. Y. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00081.x · Cited by 56
Low Use of Analgesics in Alzheimer’s Disease: Possible Mechanisms
Scherder, E. (2000) · Psychiatry · doi:10.1080/00332747.2000.11024887 · Cited by 52
Min, B.-C. (2003) · Chemical Senses · doi:10.1093/chemse/bjg066 · Cited by 36
Cited by
Biological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
Self-citationA Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought
Price, D. D., Finniss, D. G., & Benedetti, F. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.113006.095941 · Cited by 1,146
Self-citationBingel, U., Wanigasekera, V., Wiech, K., Ni Mhuircheartaigh, R., Lee, M. C., Ploner, M., & Tracey, I. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001244 · Cited by 810
The placebo response in medicine: minimize, maximize or personalize?
Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3923 · Cited by 671
Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans
Tracey, I. (2010) · Nature Medicine · doi:10.1038/nm.2229 · Cited by 553
“Importantly, these results alert us to the fact that we might not be adequately treating such patients, as they are not benefiting from the additional context-driven analgesia produced in a normal medical therapeutic setting and require more analgesics as a consequenc”
Background
Metadata
- Authors
- Benedetti, F., Arduino, C., Costa, S., Vighetti, S., Tarenzi, L., Rainero, I., & Asteggiano, G.
- Venue
- Pain
- Published
- 2006-03
- Volume
- 121
- Issue
- 1
- Pages
- 133-144
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2003292054
- Cited by
- 347
- References
- 48
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.